Recombinant Human ST3GAL4 His-tag Protein, CF Summary
Learn more about Fluorescent Glycan Labeling and DetectionProduct Specifications
Glu41-Phe333, with a C-terminal 6-His tag
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
10496-GT
| Formulation | Supplied as a 0.2 μm filtered solution in Tris and NaCl. |
| Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Assay Procedure
- Assay Buffer: 50 mM Tris, 5 mM MnCl2, pH 7.0
- Sialyltransferase Activity Kit (Catalog # EA002)
- Recombinant Human ST3GAL4 (rhST3GAL4) (Catalog # 10496-GT)
- CMP-Sialic Acid (Sigma, Catalog # C8271), 10 mM stock in deionized water
- alpha -Lactose (Sigma, Catalog # L2643), 0.3 M stock in deionized water
- 96-well Clear Plate (Catalog # DY990)
- Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
- Dilute 1 mM Phosphate Standard provided by the Sialyltransferase Activity Kit by adding 40 µL of the 1 mM Phosphate Standard to 360 µL of Assay Buffer for a 100 µM stock. This is the first point of the standard curve.
- Complete the standard curve by performing six one-half serial dilutions of the 100 µM Phosphate stock using Assay Buffer. The standard curve has a range of 0.078 to 5 nmoles per well.
- Prepare a reaction mixture containing 0.2 mM CMP-Sialic Acid, 36 mM alpha -Lactose and 2 µg/mL Coupling Phosphatase 2 (supplied in kit) in Assay Buffer.
- Dilute rhST3GAL4 to 8 µg/mL in Assay Buffer. *Note: Perform single dilution step if possible to achieve concentration and avoid any acute mechanical stresses such as vortexing.
- Load 50 µL of each dilution of the standard curve into a plate. Include a curve blank containing 50 μL of Assay Buffer.
- Load 25 µL of 8 µg/mL rhST3GAL4 into empty wells of the same plate as the curve. Include a Control containing 25 µL of Assay Buffer.
- Add 25 µL of reaction mixture to the wells, excluding the standard curve.
- Seal plate and incubate at room temperature for 30 minutes.
- Add 30 µL of the Malachite Green Reagent A (supplied in kit) to all wells. Mix briefly.
- Add 100 µL of deionized water to all wells.
- Add 30 µL of the Malachite Green Reagent B (supplied in kit) to all wells. Mix and incubate for 20 minutes at room temperature.
- Read plate at 620 nm (absorbance) in endpoint mode.
- Calculate specific activity:
Specific Activity (pmol/min/µg) = | Phosphate released* (nmol) x (1000 pmol/nmol) |
| Incubation time (min) x amount of enzyme (µg) |
*Derived from the phosphate standard curve using linear or 4-parameter fitting and adjusted for Control.
Per Reaction:- rhST3GAL4: 0.2 µg
- Coupling Phosphatase 2: 0.05 µg
- CMP-Sialic Acid: 0.1 mM
- alpha -Lactose: 18 mM
Reconstitution Calculator
Background: ST3GAL4
Sialyltransferases add sialic acid to glycoproteins or glycosphingolipids and play important roles in many biological processes including immune recognition, pathogen infection, and cell adhesion (1). ST3GAL4 is an alpha 2,3-sialyltransferase and forms alpha 2-3 linked sialic acid on the Gal residue of the terminal Gal beta 1-4GlcNAc and Gal beta 1-3GalNAc structures found on glycoproteins and glycolipids (2, 3). ST3GAL4 is involved in the synthesis of sialyl Lewis x (sLex) glycan epitope that may serve as ligands for E- and P-selectins on activated endothelial cells in inflammatory responses (4). Down-regulation of ST3GAL4 mRNA may be one of the factors associated with the malignant progression of human renal cell carcinoma (5). ST3GAL4 is expressed as a type II membrane protein localized in the trans-Golgi apparatus but may also be proteolytically processed to form a soluble form. The activity of the recombinant human ST3GAL4 was determined using a phosphatase‑coupled glycosyltransferase assay (6).
- Varki, A. (1999) Glycobiology 2:25.
- Kitagawa, H. and Paulson, J.C. (1994) J Biol Chem. 269:1394.
- Basu, S.S. et al. (1996) Biochemistry 35:5166.
- Higai, K. et al. (2006) FEBS Letters 580:1873.
- Saito, S. et al. (2002) Oncology reports 9:1251.
- Wu, Z.L. et al. (2011) Glycobiology 21:727.
Citation for Recombinant Human ST3GAL4 His-tag Protein, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
Fluorescent glycan fingerprinting of SARS2 spike proteins
Authors: ZL Wu, JM Ertelt
Scientific Reports, 2021-10-14;11(1):20428.
Species: Human
Sample Types: Recombinant Protein
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human ST3GAL4 His-tag Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human ST3GAL4 His-tag Protein, CF and earn rewards!
Have you used Recombinant Human ST3GAL4 His-tag Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
